Orchid Pharma Limited (BOM:524372)
India
· Delayed Price · Currency is INR 719.20
-4.25 (-0.59%)
At close: Jun 6, 2025
Orchid Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Cash & Equivalents | 1,796 | 36.01 | 225.97 | 43.07 | 156.94 | Upgrade
|
| Short-Term Investments | - | 0.15 | 40.15 | 0.06 | 8 | Upgrade
|
| Trading Asset Securities | 1.01 | - | - | - | 150.21 | Upgrade
|
| Cash & Short-Term Investments | 1,797 | 36.16 | 266.12 | 43.13 | 315.15 | Upgrade
|
| Cash Growth | 4871.20% | -86.41% | 517.08% | -86.32% | -64.95% | Upgrade
|
| Accounts Receivable | 2,418 | 1,955 | 2,152 | 1,706 | 1,357 | Upgrade
|
| Other Receivables | 30.44 | 48.07 | 1.58 | 0.01 | 0.71 | Upgrade
|
| Receivables | 2,449 | 2,004 | 2,154 | 1,706 | 1,358 | Upgrade
|
| Inventory | 3,264 | 2,642 | 2,287 | 1,727 | 1,529 | Upgrade
|
| Prepaid Expenses | - | 22.18 | 37.91 | 71.18 | 25.66 | Upgrade
|
| Other Current Assets | 564.36 | 3,203 | 265.17 | 429.94 | 2,271 | Upgrade
|
| Total Current Assets | 8,074 | 7,908 | 5,010 | 3,976 | 5,499 | Upgrade
|
| Property, Plant & Equipment | 6,964 | 6,360 | 6,192 | 5,931 | 6,775 | Upgrade
|
| Long-Term Investments | 496.71 | 458.4 | 444.41 | 454.98 | 4.18 | Upgrade
|
| Other Intangible Assets | 170.14 | 149.19 | 3.86 | 3.37 | 3.69 | Upgrade
|
| Other Long-Term Assets | 1,174 | 663.79 | 601.97 | 739.28 | 91.01 | Upgrade
|
| Total Assets | 16,879 | 15,539 | 12,252 | 11,106 | 12,373 | Upgrade
|
| Accounts Payable | 2,221 | 2,296 | 1,744 | 1,677 | 1,100 | Upgrade
|
| Accrued Expenses | 23.66 | 131.62 | 124.31 | 40.03 | 43.23 | Upgrade
|
| Short-Term Debt | 426.03 | 140.48 | 1,410 | 228.41 | 28.43 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 415.58 | 369.47 | 224 | Upgrade
|
| Current Portion of Leases | 3.33 | 3.33 | - | - | - | Upgrade
|
| Other Current Liabilities | 181.75 | 28.55 | 25.85 | 93.04 | 25.64 | Upgrade
|
| Total Current Liabilities | 2,856 | 2,600 | 3,719 | 2,408 | 1,421 | Upgrade
|
| Long-Term Debt | 1,316 | 1,204 | 1,488 | 2,082 | 4,275 | Upgrade
|
| Long-Term Leases | 0.37 | 3.7 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 32.26 | 32.26 | 32.26 | Upgrade
|
| Other Long-Term Liabilities | 33.87 | 24.4 | 24.89 | 23.27 | 27.26 | Upgrade
|
| Total Liabilities | 4,206 | 3,844 | 5,366 | 4,632 | 5,843 | Upgrade
|
| Common Stock | 507.19 | 507.19 | 408.16 | 408.16 | 408.16 | Upgrade
|
| Additional Paid-In Capital | - | 8,465 | 4,645 | 4,645 | 4,645 | Upgrade
|
| Retained Earnings | - | -16,180 | -17,097 | -17,558 | -17,553 | Upgrade
|
| Comprehensive Income & Other | 12,166 | 18,902 | 18,931 | 18,979 | 19,029 | Upgrade
|
| Shareholders' Equity | 12,673 | 11,695 | 6,886 | 6,474 | 6,529 | Upgrade
|
| Total Liabilities & Equity | 16,879 | 15,539 | 12,252 | 11,106 | 12,373 | Upgrade
|
| Total Debt | 1,746 | 1,352 | 3,313 | 2,680 | 4,527 | Upgrade
|
| Net Cash (Debt) | 51.25 | -1,316 | -3,047 | -2,636 | -4,212 | Upgrade
|
| Net Cash Per Share | 1.01 | -27.20 | -74.66 | -64.59 | -103.20 | Upgrade
|
| Filing Date Shares Outstanding | 50.67 | 50.72 | 40.82 | 40.82 | 40.82 | Upgrade
|
| Total Common Shares Outstanding | 50.67 | 50.72 | 40.82 | 40.82 | 40.82 | Upgrade
|
| Working Capital | 5,218 | 5,308 | 1,291 | 1,569 | 4,078 | Upgrade
|
| Book Value Per Share | 250.11 | 230.58 | 168.72 | 158.61 | 159.96 | Upgrade
|
| Tangible Book Value | 12,503 | 11,545 | 6,883 | 6,470 | 6,525 | Upgrade
|
| Tangible Book Value Per Share | 246.75 | 227.64 | 168.62 | 158.53 | 159.87 | Upgrade
|
| Land | - | 256.47 | 218.47 | 122.87 | 122.87 | Upgrade
|
| Buildings | - | 1,849 | 1,783 | 1,439 | 1,439 | Upgrade
|
| Machinery | - | 10,773 | 10,097 | 10,095 | 10,092 | Upgrade
|
| Construction In Progress | - | 163.94 | 464.63 | 97.84 | 74.31 | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.